Navigation Links
Volcano Corporation to Offer $100 Million Convertible Senior Notes Due 2015
Date:9/13/2010

ith the option counterparty, which could have a dilutive effect on the company's common stock to the extent that the market value per share of the company's common stock, as measured under the warrant transaction, exceeds the strike price of the warrant transaction.  If the underwriter exercises its overallotment option to purchase additional notes, the company expects to enter into an additional convertible note hedge transaction and an additional warrant transaction.

In connection with establishing its initial hedge position with respect to the convertible note hedge transaction and the warrant transaction, the option counterparty, and/or its affiliates, expects to enter into various over-the-counter derivative transactions with respect to the company's common stock concurrently with and/or shortly after the pricing of the notes.  These activities could have the effect of increasing, or limiting a decline in, the market price of the company's common stock concurrently with and/or shortly after the pricing of the notes.

In addition, the option counterparty and/or its affiliates may modify its hedge position from time to time prior to conversion or maturity of the notes by entering into and unwinding various over-the-counter derivative transactions and/or purchasing and selling shares of the company's common stock and the company's other securities, including the notes and/or other instruments it may wish to use in connection with such hedging activities (and is likely to do so during any observation period related to a conversion of notes).

J.P. Morgan Securities LLC is the sole manager of the note offering. The notes will be offered and sold under Volcano's shelf registration statement filed with the Securities and Exchange Commission (SEC) on September 13, 2010, which was effective upon filing.  Before you invest, you should read the prospectus and prospectus supplement to that registration statement and other documents Volcano
'/>"/>

SOURCE Volcano Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Volcano Sponsors First Study Designed to Determine if IVUS Can Identify Patients at Risk for Stent Thrombosis and to Demonstrate the Benefit of IVUS Guidance for Procedural Outcome
2. Volcano Announces Participation in SATURN Clinical Trial Sponsored by AstraZeneca
3. Volcanos VH(R) IVUS Technology Used in Imaging Study of GlaxoSmithKlines Novel Investigational Compound, Darapladib
4. Volcano Corporation Schedules Third Quarter Conference Call, Webcast
5. Volcano Corporation Announces Litigation Status
6. Volcano Corporation Presentation at Canaccord Adams Conference to Be Webcast
7. Volcano Corporation Announces Preliminary Record Revenues for Fourth Quarter 2009; Total Year Revenues are Expected to Exceed Prior Guidance
8. Volcano Corporation Commends the Elevation of FFR to Level of Evidence A in New PCI Guidelines
9. Volcano Announces Installed Base Growth Milestone
10. Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging
11. Volcano Corporation Completes Acquisition of Lumen Biomedicals Xtract(TM) Thrombus Aspiration Catheter
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/7/2015)... 7 de julio de 2015 Sequent ... privada centrada en el desarrollo de dispositivos innovadores ... anunciado hoy que R. Michael Kleine ... Kleine cuenta con más de 25 ... dispositivos médicos y la sanidad. Ha gestionado con ...
(Date:7/7/2015)... , July 7, 2015 According to ... Method (Manual, Automated), Product (Consumables, Instrument), Application (Aerobic, Anaerobic, Yeast/ ... Research Institute) - Forecast to 2019", published by MarketsandMarkets, The ... Million by 2019 from $2,750.2 Million in 2014 at a ... 1 78 ma rket data ...
(Date:7/7/2015)... Accelovance, Inc. (Accelovance), a global contract ... General Medicine announced the completion of enrollment and ... Therapeutics, Inc. for the Phase 3 trial of ... SUSTOL® (granisetron injection, extended release) as part of ... receptor antagonist fosaprepitant and IV corticosteroid dexamethasone ...
Breaking Medicine Technology:Sequent Medical nombra a Mike Kleine a su junta directiva 2Sequent Medical nombra a Mike Kleine a su junta directiva 3Blood Culture Tests Market Worth $3,893.5 Million by 2019 2Blood Culture Tests Market Worth $3,893.5 Million by 2019 3Blood Culture Tests Market Worth $3,893.5 Million by 2019 4Accelovance Completes Trial Enrollment and Delivery of Clinical Data for Heron Therapeutics' Phase 3 Trial 2
... WIRE)--May 15, 2007 - Synthetic Blood,International, Inc. ... analysis of its Phase IIa study with ... line with preliminary,study results announced in December ... of increasing patients' oxygen,tension levels compared with ...
... WIRE)--May 17, 2007 - Salix,Pharmaceuticals, Ltd. (NASDAQ:SLXP) today ... the Company's products,will be presented at Digestive Disease ... Digestive Disease Week is considered the,largest and most ... Every year it attracts more than 16,000 physicians,researchers ...
Cached Medicine Technology:Positive Statistical Analysis from Synthetic Blood's Oxycyte,Traumatic Brain Injury Trial Indicates Achievement of Primary,Endpoint 2Positive Statistical Analysis from Synthetic Blood's Oxycyte,Traumatic Brain Injury Trial Indicates Achievement of Primary,Endpoint 3Salix Pharmaceuticals Previews Digestive Disease Week 2007 2Salix Pharmaceuticals Previews Digestive Disease Week 2007 3Salix Pharmaceuticals Previews Digestive Disease Week 2007 4Salix Pharmaceuticals Previews Digestive Disease Week 2007 5
(Date:7/7/2015)... (PRWEB) , ... July 07, 2015 , ... ... Times highlights rumors about possible facial rejuvenation that have emerged about Hillary Clinton. ... U.S. Secretary of State looks more youthful than she has in some time ...
(Date:7/7/2015)... ... , ... Greatist today announced the acquisition of Blood, Sweat ... most fun activities to do with friends. , The acquisition of BSC strengthens Greatist’s ... for events, e-commerce, and brand partnerships. , “I’ve been a huge fan of Blood, ...
(Date:7/7/2015)... ... July 07, 2015 , ... Illinois cannabis cultivation centers ... to permit holders. The Medical Cannabis Alliance of Illinois’ (MCAI) board and its ... are committed to making sure patients have access to cannabis as a viable ...
(Date:7/7/2015)... ... ... the end of June Pacific Prime Renewals team in Hong Kong announced that they ... Renewals Manager, Danielle Cotton, aims to not only reduce but eventually eliminate the use of ... send anything between 300 and 600 pieces of paper per month. Not to mention A4 ...
(Date:7/7/2015)... ... July 07, 2015 , ... ... enhance the experience for its patient community using its IDF ePHR, an electronic ... with primary immunodeficiency diseases (PI) to easily track their health information, including symptoms, ...
Breaking Medicine News(10 mins):Health News:Recent Article on Hillary Clinton Plastic Surgery Speculation Illuminates the Reasons Many Professionals Explore Facial Rejuvenation, says Dr. J 2Health News:Recent Article on Hillary Clinton Plastic Surgery Speculation Illuminates the Reasons Many Professionals Explore Facial Rejuvenation, says Dr. J 3Health News:Greatist Acquires Active Lifestyle Brand Blood, Sweat & Cheers 2Health News:Cannabis Growers and Dispensaries Form Medical Cannabis Alliance of Illinois 2Health News:Pacific Prime Hong Kong Renewals Team Starts Push to go Green 2Health News:Get Real Health Launches New Mobile App for Immune Deficiency Foundation Patient Community 2Health News:Get Real Health Launches New Mobile App for Immune Deficiency Foundation Patient Community 3
... 6 Osteotech, Inc.,(Nasdaq: OSTE ) announced today ... million from third quarter 2006 revenue of $23.4,million. Revenue ... $17.6 million for the three months ended September 30,2007 ... same segments for the,third quarter of 2006. Gross margin ...
... Thursday, November 8,2007, at 8:30 a.m. Eastern/2:30 p.m. Central ... CTIC and MTAX: CTIC),management team will host ... quarter achievements and financial results. Conference Call ... a.m. Eastern/2:30 p.m. Central European/5:30 a.m. Pacific Time ...
... Nov. 6 Rigel,Pharmaceuticals, Inc. (Nasdaq: RIGL ) today ... September 30, 2007. For the third quarter of 2007, ... share, compared to a net loss of $11.4 million, or,$0.46 ... shares,outstanding for the third quarters of 2007 and 2006 were ...
... - Elsevier Signs Agreement With Bayer HealthCare ... healthcare company, Bayer,HealthCare AG, headquartered in Leverkusen, Germany, ... in electronic format for,the first time, EMBASE Classic ... Excerpta Medica Abstract Journals published between 1947 and,1973. ...
... NASDAQ: CRME TSX: COM, VANCOUVER, Nov. 5 /PRNewswire-FirstCall/ ... announced that Bob Rieder, Chairman and,Chief Executive Officer, will ... Annual Healthcare Conference in New York at 1:20pm Eastern,Time ... A live webcast of Mr. Rieder,s presentation can be ...
... Nov. 5 StatSure Diagnostic,Systems, Inc. (OTC Bulletin ... Drug Administration ("FDA"), through its Center for Devices ... Clinical Laboratory,Improvements Amendments of 1988 ("CLIA") for an ... technology. The HIV 1/2 product,is marketed and distributed ...
Cached Medicine News:Health News:Osteotech Reports 2007 Third Quarter Financial Results; Core Segment Revenue Increased 28%; Gross Margin Improved to 55%; Diluted Earnings Per Share of $.09 2Health News:Osteotech Reports 2007 Third Quarter Financial Results; Core Segment Revenue Increased 28%; Gross Margin Improved to 55%; Diluted Earnings Per Share of $.09 3Health News:Osteotech Reports 2007 Third Quarter Financial Results; Core Segment Revenue Increased 28%; Gross Margin Improved to 55%; Diluted Earnings Per Share of $.09 4Health News:Osteotech Reports 2007 Third Quarter Financial Results; Core Segment Revenue Increased 28%; Gross Margin Improved to 55%; Diluted Earnings Per Share of $.09 5Health News:Rigel Announces Third Quarter 2007 Financial Results 2Health News:Rigel Announces Third Quarter 2007 Financial Results 3Health News:Rigel Announces Third Quarter 2007 Financial Results 4Health News:EMBASE Classic Makes Inroads into Pharmaceutical Industry 2Health News:EMBASE Classic Makes Inroads into Pharmaceutical Industry 3Health News:Cardiome to Present at CIBC Conference 2Health News:Cardiome to Present at CIBC Conference 3Health News:StatSure's Patented HIV 'Barrel' Technology Receives CLIA Waiver From FDA 2Health News:StatSure's Patented HIV 'Barrel' Technology Receives CLIA Waiver From FDA 3
... series slit lamp biomicroscopy ... & small pupil exams. ... capability, specifically addressing maximum ... fundus image resolution & ...
Volk indirect lenses. General diagnosis / small pupil examinations....
... contact class is particularly suitable ... which have a smaller distance ... reduction prism than the Haag-Streit ... / iridocornea. Mirror angle 59° ...
... the standard for steam Sterilization. The Tuttnauer ... healthcare and laboratory facility. Our basic manual ... needs. Time tested reliability and durability are ... M Series is also available in a ...
Medicine Products: